@article{3cff18053e384da68a5c886ad59ea12f,
title = "Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia",
keywords = "AZD3480, Cognitive dysfunction, Neuronal nicotinic acetylcholine receptor, Schizophrenia",
author = "Dawn Velligan and Ronald Brenner and Franco Sicuro and David Walling and Robert Riesenberg and Adonis Sfera and Charles Merideth and Dennis Sweitzer and Judith Jaeger",
note = "Funding Information: This study was funded by AstraZeneca Pharmaceuticals. The sponsor was also responsible, with input and support from the investigators, for the design and implementation of the study, the analysis and interpretation of the data, the preparation of the study report, and the decision to publish. AstraZeneca also provided funding for editorial support. ",
year = "2012",
month = jan,
doi = "10.1016/j.schres.2011.10.004",
language = "English",
volume = "134",
pages = "59--64",
journal = "Schizophrenia Research",
issn = "0920-9964",
number = "1",
}